At BioSTAR we are focusing on the healing power of placental tissue.

Over the last three years, BioSTAR developed a new technology called placenTX which is a flowable tissue allograft comprised of structural extracellular matrix (ECM) derived from placental tissue.

placenTX is harvested using a proprietary process where the normally insoluble or partially soluble ECM components are partitioned into a flowable fraction.

BioSTAR’s products are not currently available for distribution.